The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 9, 2023 | NEA Partners 13, Limited Partnership | 10% Owner | Buy(P) | 24.4M | $0.20 | $4.9M |
| Jul 19, 2022 | Sung Derrick | Director | Grant(A) | 87K | $2.30 | $200K |
| Jun 10, 2022 | Anderson Jill | Director | Grant(A) | 50K | $2.41 | $120K |
| Jun 10, 2022 | Coste Catherine | Director | Grant(A) | 50K | $2.41 | $120K |
| Jun 10, 2022 | Hunt Niquette L. | Director | Grant(A) | 50K | $2.41 | $120K |
| Jun 10, 2022 | Renzi David | Director | Grant(A) | 50K | $2.41 | $120K |
| Jun 10, 2022 | Jaffe Ross A MD | Director | Grant(A) | 50K | $2.41 | $120K |
| Jun 10, 2022 | Behbahani Ali | Director | Grant(A) | 50K | $2.41 | $120K |
| May 2, 2022 | Clapper David M | President and CEO, Director | Grant(A) | 230K | — | $0 |
| May 2, 2022 | Jung Joel R | CFO | Grant(A) | 60K | — | $0 |
| May 2, 2022 | Filloux Dominique J. | COO | Grant(A) | 60K | — | $0 |
| May 2, 2022 | Skalnyi Evgueni V. | VP Medical Affairs | Grant(A) | 50K | — | $0 |
| Dec 15, 2021 | Clapper David M | President and CEO, Director | Grant(A) | 94K | — | $0 |
| Dec 15, 2021 | Filloux Dominique J. | COO | Grant(A) | 25K | — | $0 |
| Dec 15, 2021 | Jung Joel R | CFO | Grant(A) | 25K | — | $0 |
| Dec 15, 2021 | Skalnyi Evgueni V. | VP Medical Affairs | Grant(A) | 20K | — | $0 |
| Dec 13, 2021 | Clapper David M | President and CEO, Director | Buy(P) | 25K | $4.94 | $124K |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 95K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 25K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 280K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 25K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 396K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 396K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 10K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 1.7M | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 438 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 3K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 879K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 6K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 500K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 818K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 787K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 776K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 835K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 72K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 70K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 69K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 74K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 455 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 438 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 432 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 464 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 72K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 70K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 69K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 74K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 455 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 432 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 464 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 95K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 25K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 396K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 396K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 280K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 25K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 35K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 2K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 284K | — | — |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 818K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 787K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 776K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 835K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 5K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 72K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 70K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 69K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 74K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 455 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 438 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 432 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 464 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 72K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 70K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 69K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 74K | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 455 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 438 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 432 | — | $0 |
| Oct 26, 2021 | Jaffe Ross A MD | Director | Conversion(C) | 464 | — | $0 |
| Oct 26, 2021 | Novo Holdings A/S | 10% Owner | Conversion(C) | 593K | — | — |
| Oct 26, 2021 | Novo Holdings A/S | 10% Owner | Conversion(C) | 884K | — | — |
| Oct 26, 2021 | Novo Holdings A/S | 10% Owner | Buy(P) | 580K | $12.00 | $7.0M |
| Oct 26, 2021 | Novo Holdings A/S | 10% Owner | Conversion(C) | 0 | — | — |
| Oct 26, 2021 | Novo Holdings A/S | 10% Owner | Conversion(C) | 884K | — | — |
| Oct 26, 2021 | New Enterprise Associates 13 LP | 10% Owner | Conversion(C) | 596K | — | — |
| Oct 26, 2021 | New Enterprise Associates 13 LP | 10% Owner | Conversion(C) | 1.2M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).